Patients with T2DM have been reported to have high levels of circulating inflammatory cytokines which include TNF-α, IL-1β, IL-6, monocyte chemoattractant protein-1 (MCP-1) and C-reactive protein, suggesting an increased risk of tissue injury [40,41]. Here, CCL2 is linked to type 2 diabetes mellitus.